REFERENCES
- Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990; 346: 371–374.
- Border WA, Noble NA, Yamamoto T, Tomooka S, Kagami S. Antagonists of transforming growth factor-β: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis. Kidney Int 1992; 41: 566–570.
- Flanders KC, Thompson NL, Cissel DS, et al. Transforming growth factor-β1: histochemical localization with antibodies to different epitopes. J Cell Biol 1989; 108: 653–660.
- Hooke DH, Gee DC, Atkins RC. Leukocyte analysis using mono-clonal antibodies in human glomerulonephritis. Kidney Int 1987; 31: 964–972.
- Leung J, Lai C, Chui YL, Ho R, Chan C, Lai KN. Characterization of cytokine gene expression in CD4+ and CD8+ T cells after activation with phorbol myristate acetate and phytohaemagglutinin. Clin Exp Immunol 1992; 90: 147–153.
- Nakamura T, Osoda S, Ebihara I, Horikoshi S, Tomino Y, Koide H. Growth factor mRNA in glomeruli from focal glomerulosclerosis. J Am Soc Nephrol 1991; 2: 443 (abstract).
- Noh JW, Wiggins R, Phan SH. Urine transforming growth factor-β activity is related to the degree of scarring in crescentic nephritis in the rabbit. Nephron 1993; 63: 73–78.
- Stachura I, Si L, Madan E, Whiteside T. Mononuclear cell subsets in human renal disease. Enumeration in tissue sections with monoclonal antibodies. Clin Immunol Immunopathol 1984; 30: 362–373.
- Yoshioka K, Takemura T, Murakami K, et al. In situ expression of cytokines in IgA nephritis. Kidney Int 1993; 44: 825–833.
- Yoshioka K, Takemura T, Murakami K, et al. Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 1993; 68: 154–163.